RVTY — tear sheet

The engine's decision rates RVTY Sell — a trim to roughly half of standard benchmark weight, not a full exit, with no new long or short exposure under its plan; the plan labels the stance Underweight (engine final decision). Core evidence: a single-session QuantOrb money-flow snapshot for the 2026-09-17 US session (MFI 69.06; CONTINUATION at 0.5905) that the source itself calls a quantitative screen output, not a recommendation ([FACTS]). Per the quantorb 13F dataset (five filer rows as of 2026-03-31, roughly 5.5 months stale per the engine), EdgePoint — about 93% of tracked shares — added 265,204 (+3.1%) while Eversept cut 77,923 (-47.9%); the engine reads the net +190,189 tracked-share change as one manager's behavior, not broad institutional sentiment ([THIRTEENF]). No 8-K Item 2.02 appears in the lookback window and the 10-K MD&A excerpt carries no financial figures ([EIGHTK], [FILING]); the filing describes a health-science franchise in more than 160 countries with about 11,000 employees, context the engine weighs against a full exit. Sources: [FACTS], [FILING], [EIGHTK], [THIRTEENF]; engine final decision.

Source: SEC 13F-HR holdings (as of 2026-03-31) via quantorb filers data — quarter-end snapshots, statutory lag up to 45 days

Quarter-end 13F-HR snapshot for RVTY as tracked in the quantorb filers dataset (5 institutional filer rows on file; positions as of 2026-03-31, a quarter-end snapshot subject to the statutory 13F reporting lag of up to 45 days). Quarter-over-quarter share changes where the dataset carries them:

This is the dataset's tracked top-holder snapshot, not an exhaustive list of 13F filers; it is a periodic regulatory disclosure, not real-time portfolio data.

Management's corpus disclosure is the 10-K filed 2026-02-24: Revvity describes itself as a leading health-science solutions provider with workflows from discovery to development and diagnosis to cure — translational multi-omics, biomarker identification, imaging, screening, detection, diagnosis and informatics among its focus areas — marketing in more than 160 countries with about 11,000 employees as of December 28, 2025, NYSE-listed as RVTY and an S&P 500 component ([FILING]). Its MD&A carries standard forward-looking-statement caution — actual results may differ materially — and no financial figures; results and guidance specifics are not available in provided documents ([FILING]). No 8-K Item 2.02 press release was found in the lookback window, so the corpus holds no recent results disclosure from management ([EIGHTK]). Catalysts the engine anchors re-evaluation on: the next 8-K Item 2.02 with actual financials, fresh Q2/Q3 2026 13F data (whether EdgePoint maintained or added, and Eversept's trajectory), and any session with live price/ATR data; earnings timing is not available in provided documents (engine final decision). Sources: [FILING], [EIGHTK], [THIRTEENF]; engine final decision.

Signal quality: the QuantOrb print is a single-session snapshot (2026-09-17 US session, a day old per the conservative reviewer), with CONTINUATION strength of 0.5905 — barely above a coin flip — and MFI 69.06 about 0.94 points under the conventional overbought line of 70 ([FACTS]; risk review). Monitoring gaps: price, RSI, MACD, ATR and trajectory history are not available in provided documents, so the neutral reviewer calls the engine's falsification triggers unmonitorable — 'instruments that aren't installed' ([FACTS]; risk review). Data limitations: the quantorb 13F snapshot (as of 2026-03-31, five filer rows, non-exhaustive, statutory lag up to 45 days) is roughly 5.5 months stale per the engine; EdgePoint holds about 93% of tracked shares while Eversept cut 47.9%, so the net +190,189-share change reflects one manager's behavior, not broad institutional sentiment ([THIRTEENF]). Fundamental absence: no 8-K Item 2.02 and no revenue, margin or guidance figures — not available in provided documents ([EIGHTK], [FILING]). News, StockTwits and Reddit sentiment channels returned no data (sentiment analyst report). Sources: [FACTS], [THIRTEENF], [EIGHTK], [FILING]; engine risk review.